Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
specificAn acute lymphoblastic leukemia of B-lineage origin.
16
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Precursor B-Cell Lymphoblastic Leukemia-Lymphoma(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 53.1 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 53.1 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 53.1 |
| 4 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 53.1 |
| 5 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 53.1 |
| 6 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 53.1 |
| 7 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 53.1 |
| 8 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 53.1 |
| 9 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 53.1 |
| 10 | University of Illinois Cancer CenterChicago, IL | 53.1 |
| 11 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical | 53.1 |
| 12 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 53.1 |
| 13 | Boston University Cancer CenterBoston, MA | 53.1 |
| 14 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 53.1 |
| 15 | University of Cincinnati Cancer CenterCincinnati, OH | 53.1 |
| 16 | 53.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →